Bis-PEG21-NHS ester is a bifunctional PEG linker optimized for antibody-drug conjugates, providing extended hydrophilic spacing. Its dual NHS groups allow efficient amine coupling, facilitating stable and homogeneous conjugate formation in targeted therapies.
Structure of 2221948-98-5
* For research and manufacturing use only. We do not sell to patients.
Size | Price | Stock | Quantity |
---|---|---|---|
-- | $-- | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
Bis-PEG21-NHS ester, a versatile bifunctional crosslinker, plays a pivotal role in bioconjugation and drug delivery applications. Here are four key applications of Bis-PEG21-NHS ester presented with high perplexity and burstiness:
Protein Conjugation: Widely utilized in the realm of biochemistry, Bis-PEG21-NHS ester serves as a robust tool for covalently connecting proteins to various biomolecules, such as peptides or antibodies, thereby enhancing their functionality. Through the interaction with lysine residues on proteins, it facilitates the creation of enduring conjugates pivotal in the development of cutting-edge diagnostic assays and precisely targeted therapies.
Drug Delivery: Spearheading advancements in drug delivery, Bis-PEG21-NHS ester is instrumental in linking therapeutic agents to carrier molecules like nanoparticles or liposomes, thus enhancing their solubility, stability, and biocompatibility. This PEGylation process not only improves the pharmacokinetic profile of drugs but also reduces the immunogenicity of therapeutic agents, heralding a new era in drug delivery systems.
Surface Modification: Delving into the realm of surface engineering, Bis-PEG21-NHS ester emerges as a key player in modifying medical devices and biosensors to mitigate nonspecific binding and enhance biocompatibility. By affixing PEG chains to surfaces, it constructs a hydrophilic shield that thwarts protein adsorption and cell adhesion, particularly vital in crafting implants and diagnostic devices with reduced fouling and superior operational efficiency.
Hydrogel Formation: In the domain of tissue engineering and regenerative medicine, Bis-PEG21-NHS ester showcases its prowess in hydrogel synthesis by crosslinking polyethylene glycol (PEG) polymers. This process engenders a sophisticated three-dimensional scaffold capable of encapsulating cells and bioactive molecules, fostering cell proliferation and differentiation - offering a beacon of hope in the creation of intricate tissue constructs and advanced delivery systems.
Catalog | Product Name | CAS | Inquiry |
---|---|---|---|
BADC-00379 | Bis-PEG4-NHS ester | 1314378-11-4 | |
BADC-00380 | Bis-PEG3-NHS Ester | 1314378-16-9 | |
BADC-00924 | Bis-PEG7-NHS ester | 1334170-02-3 | |
BADC-00960 | Bis-PEG6-NHS ester | 1526718-98-8 | |
BADC-01080 | Bis-PEG17-NHS ester | 2221948-93-0 | |
BADC-01081 | Bis-PEG25-NHS ester | 2221948-96-3 | |
BADC-01083 | Bis-PEG13-NHS ester | 2221949-00-2 | |
BADC-01084 | Bis-PEG10-NHS ester | 2221949-02-4 | |
BADC-00381 | Bis-PEG2-NHS Ester | 65869-63-8 | |
BADC-00382 | Bis-PEG1-NHS ester | 65869-64-9 |
Contact our experts today for pricing and comprehensive details on our ADC offerings.
From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.
Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.
Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.